About this trial
The purpose of this study is to determine if an acute bout of removal of exercise reduces enothelial function and glycemic control in an active, older adult population; and whether a 3 day return to exercise restores this response. Glycemic control is the blood glucose response following the consumption of a meal. It is an indicator of insulin resistance (or type 2 diabetes) and impaired glycemic control has been suggested to lead to cardiovascular disease. Endothelial function has been shown to be improved by chronic or acute increases in physical activity. Both of these have been shown to be impaired to acute bouts of inactivity in young populations; however the impact of acute inactivity in older adults is less understood. In this proposal the investigators will examine 1)how quickly impairments in glycemic control occur to acute physical inactivity in older adults who exercise, 2) how quickly impairments in endothelial function occur to acute inactivity in older adults who exercise, and 3) whether 3 days of a return to exercise restores these responses.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
55 years and older, 18-40 years old
Healthy, physically active, performing at least 90 min/week of physical activity
Free of physical limitations that may interfere with alterations in daily physical activity levels
Disqualifiers
Physician diagnosed HIV, hepatitis, or tuberculosis.
Body weight change of greater than 5% within the previous 2 months
Smoking within the previous 2 months.
Taking medications that alter blood glucose levels
Trial design
Crossover
Treatments tested in this trial
removal of exercise
Other interventionSubjects will stop doing their normal exercise routines for 3 or 5 days and then subjects will resume doing their normal exercise routines for 3 days.
Treatment groups
Trial outcomes
Primary outcomes
Continuous glucose monitoring
Continuous glucose monitoring
Continuous glucose monitoring
Flow mediated dilation
This measure assess blood vessel health non-invasively
Sponsors and contacts
Click on the lead sponsor to view all of their trials.